BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32514927)

  • 21. [Extranodal NK/T-cell lymphoma].
    Suzuki R
    Nihon Rinsho; 2014 Mar; 72(3):524-30. PubMed ID: 24724414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Third cranial nerve palsy caused by intracranial extension of a sino-orbital natural killer T-cell lymphoma.
    Chen CS; Miller NR; Lane A; Eberhart C
    J Neuroophthalmol; 2008 Mar; 28(1):31-5. PubMed ID: 18347456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Thyroid Extranasal NK/T-Cell Lymphoma Associated With Good Outcome: A Case Report and Literature Review: A Care-Compliant Article.
    Li JH; He HH; Cheng Y; He WJ
    Medicine (Baltimore); 2016 May; 95(20):e3460. PubMed ID: 27196451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features and prognostic model for extranasal NK/T-cell lymphoma.
    Jo JC; Yoon DH; Kim S; Lee BJ; Jang YJ; Park CS; Huh J; Lee SW; Ryu JS; Suh C
    Eur J Haematol; 2012 Aug; 89(2):103-10. PubMed ID: 22553935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus associated extranodal natural killer T cell lymphoma of nasal type mimicking pyogenic osteomyelitis of the proximal humerus.
    Wong T; Ko JY; Wang FS; Chen YJ; Ma MC
    Chang Gung Med J; 2008; 31(3):314-9. PubMed ID: 18782956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extranodal NK/T-cell lymphoma, nasal type: report of 15 cases.
    Tababi S; Kharrat S; Sellami M; Mamy J; Zainine R; Beltaief N; Sahtout S; Besbes G
    Eur Ann Otorhinolaryngol Head Neck Dis; 2012 Jun; 129(3):141-7. PubMed ID: 22321911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases.
    Tomoka T; Powers E; van der Gronde T; Amuquandoh A; Dhungel BM; Kampani C; Kamiza S; Montgomery ND; Fedoriw Y; Gopal S
    BMC Cancer; 2017 Sep; 17(1):633. PubMed ID: 28877678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy.
    Yamaguchi M; Takata K; Yoshino T; Ishizuka N; Oguchi M; Kobayashi Y; Isobe Y; Ishizawa K; Kubota N; Itoh K; Usui N; Miyazaki K; Wasada I; Nakamura S; Matsuno Y; Oshimi K; Kinoshita T; Tsukasaki K; Tobinai K
    Cancer Sci; 2014 Nov; 105(11):1435-41. PubMed ID: 25181936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case Report of Primary Nasal Natural Killer (NK)/T-Cell Lymphoma in an African American Patient Presenting with Hemophagocytic Syndrome.
    Tan B; Abdelmalek C; O'Donnell JE; Toltaku T; Chaudhry R; Wang JC; Gotlieb V
    Am J Case Rep; 2017 Feb; 18():160-165. PubMed ID: 28193996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjunctival extranodal natural killer/T-cell lymphoma, nasal type.
    Kiratli H; Uzun S; Yeşilirmak A; Ayhan AS; Soylemezoğlu F
    Cornea; 2015 Jun; 34(6):710-2. PubMed ID: 25811726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extranodal NK/T-cell lymphoma, nasal type, with extranasal presentation - a case report and a review of the literature.
    Akbar M; Clasen-Linde E; Specht L
    Acta Oncol; 2020 Dec; 59(12):1480-1487. PubMed ID: 32689856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Series of extranodal natural killer/T-cell lymphoma, nasal type, with periorbital involvement.
    Termote K; Dierickx D; Verhoef G; Jorissen M; Tousseyn T; Mombaerts I
    Orbit; 2014 Aug; 33(4):245-51. PubMed ID: 24831171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extranodal natural killer/T-cell lymphoma, nasal-type.
    Chorianopoulos D; Samitas K; Vittorakis S; Kiriazi V; Rondoyianni D; Tsaousis G; Skoutelis A
    Skinmed; 2010; 8(1):56-8. PubMed ID: 20839428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK-Cell Lymphomas.
    Chihara D; Oki Y
    Cancer Treat Res; 2019; 176():163-184. PubMed ID: 30596218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Burkitt's lymphoma in a patient with systemic lupus erythematosus treated with immunosuppressive drugs. A case report].
    Bellier C; Khellaf M; Lambotte O; Godeau B
    Rev Med Interne; 2006 Mar; 27(3):244-7. PubMed ID: 16406163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extranodal NK/T cell lymphoma, nasal type: An updated overview.
    Sánchez-Romero C; Bologna-Molina R; Paes de Almeida O; Santos-Silva AR; Prado-Ribeiro AC; Brandão TB; Carlos R
    Crit Rev Oncol Hematol; 2021 Mar; 159():103237. PubMed ID: 33493634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous peripheral T-cell lymphoma of cytotoxic phenotype mimicking extranodal NK/T-cell lymphoma.
    Pan ST; Chang WS; Murphy M; Martinez A; Chuang SS
    Am J Dermatopathol; 2011 Apr; 33(2):e17-20. PubMed ID: 21252637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.
    Cao J; Lan S; Shen L; Si H; Zhang N; Li H; Guo R
    Oncotarget; 2017 Mar; 8(12):20362-20370. PubMed ID: 27901491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
    Suzuki R
    Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.